Survey of Institutional Policies for Provision of “CMV-Safe” Blood in Ontario
- 15 November 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 146 (5) , 578-584
Abstract
Objectives: Debate continues on whether leukoreduction alone (LR) is sufficiently similar to leukoreduced cellular products drawn from cytomegalovirus (CMV)–seronegative (SN) donors to minimize the risk of transfusion-transmitted CMV (TT-CMV). We sought to determine the policy, inventory, and practice landscape of the province for TT-CMV mitigation. Methods: A web-based survey was distributed to hospitals in Ontario by Canadian Blood Services to collect data on their policies with respect to TT-CMV prevention. Results: TT-CMV mitigation practices varied by patient population, hospital size, and region. Smaller institutions remain committed to dual prevention, whereas academic hospitals favor a single-measure approach. Although smaller institutions attempt to align their policies with leadership sites, emulation is often inaccurate. The demands for SN products also appear to be significantly lower than the current screening practices of Canadian Blood Services. Conclusions: Standardization is lacking on practices to prevent TT-CMV. Although there are barriers to harmonizing practices, the apparent shift to policies acknowledging LR as a sufficient protection is likely to continue.Keywords
This publication has 23 references indexed in Scilit:
- Hitting the “tipping point” of TRICC?Transfusion, 2010
- Direct assessment of cytomegalovirus transfusion‐transmitted risks after universal leukoreductionTransfusion, 2010
- Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegativeVox Sanguinis, 2009
- Prevention of transfusion‐transmitted cytomegalovirus: reactivation of the debate?Transfusion, 2007
- Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood productsBlood, 2003
- Disseminating Innovations in Health CareJAMA, 2003
- Cytomegalovirus Infectivity in Whole Blood Following Leukocyte Reduction by FiltrationAmerican Journal of Clinical Pathology, 2001
- Medical Education in the United States: A Resource for the Third World?Health Affairs, 1984
- Infections Due to Herpesviruses in Cardiac Transplant Recipients: Role of the Donor Heart and Immunosuppressive TherapyThe Journal of Infectious Diseases, 1983
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981